Oaktree Acquisition Corp. III Life Sciences (OACC) Total Liabilities (2024 - 2026)

Oaktree Acquisition Corp. III Life Sciences has reported Total Liabilities for 3 years, with the latest figure at $8.6 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 7.0% year-over-year to $8.6 million; the trailing twelve-month figure through Mar 2026 stood at $8.6 million (up 7.0% YoY), and the FY2025 full-year result was $8.3 million, up 7.39% from the prior year.
• Total Liabilities for Q1 2026 stood at $8.6 million, up from $8.3 million in the prior quarter.
• The five-year high for Total Liabilities was $8.6 million in Q1 2026, with the low at $7.7 million in Q4 2024.
• Historically, Total Liabilities has averaged $8.2 million across 3 years, with a median of $8.2 million in 2025.
• Annual changes were most pronounced in 2025 — Total Liabilities rose 7.39% — and 2026, when it grew 7.0%.
• Oaktree Acquisition Corp. III Life Sciences' Total Liabilities stood at $7.7 million in 2024, then increased by 7.39% to $8.3 million in 2025, then grew by 3.9% to $8.6 million in 2026.
• The last three Total Liabilities figures came in at $8.6 million (Q1 2026), $8.3 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.